社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
trace10
IP属地：未知
+关注
帖子 · 71
帖子 · 71
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
trace10
trace10
·
2021-12-27
Buy
$ARK Innovation ETF(ARKK)$
[Thinking] [Victory]
非常抱歉，此主贴已删除
看
3,625
回复
评论
点赞
4
编组 21备份 2
分享
举报
trace10
trace10
·
2021-12-08
Heading in the right direction [Grin]
非常抱歉，此主贴已删除
看
3,705
回复
1
点赞
5
编组 21备份 2
分享
举报
trace10
trace10
·
2021-12-07
Taking a breather
Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>
Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Se
Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>
看
3,812
回复
3
点赞
4
编组 21备份 2
分享
举报
trace10
trace10
·
2021-12-07
Great news [Grin]
Stocks linked to the reopening of the economy gained on Monday<blockquote>与经济重新开放相关的股票周一上涨</blockquote>
Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel book
Stocks linked to the reopening of the economy gained on Monday<blockquote>与经济重新开放相关的股票周一上涨</blockquote>
看
2,914
回复
评论
点赞
5
编组 21备份 2
分享
举报
trace10
trace10
·
2021-12-04
Do we REALLY need another vaccine shot to counter Omicron???[Facepalm]
Novavax stock surged more than 7% in premarket trading<blockquote>Novavax股价在盘前交易中飙升逾7%</blockquote>
Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron
Novavax stock surged more than 7% in premarket trading<blockquote>Novavax股价在盘前交易中飙升逾7%</blockquote>
看
2,835
回复
评论
点赞
1
编组 21备份 2
分享
举报
trace10
trace10
·
2021-12-04
Vaccine manufactures are the big winners in this pandemic[Allin] [USD]
Moderna stock jumped more than 5% in premarket trading<blockquote>Moderna股价在盘前交易中上涨超过5%</blockquote>
Moderna stock jumped more than 5% in premarket trading because Moderna led with antibody response in
Moderna stock jumped more than 5% in premarket trading<blockquote>Moderna股价在盘前交易中上涨超过5%</blockquote>
看
2,722
回复
评论
点赞
1
编组 21备份 2
分享
举报
trace10
trace10
·
2021-12-01
OMG....the vaccine manufacturers need several months to mass produce a vaccine that would be effective against omicron [流泪]
非常抱歉，此主贴已删除
看
2,600
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
trace10
trace10
·
2021-11-29
More rounds of vaccinations [白眼]
Moderna says new Covid-19 vaccine for Omicron may be ready in early 2022<blockquote>Moderna表示针对奥密克戎的新Covid-19疫苗可能于2022年初准备就绪</blockquote>
Moderna chief medical officer Paul Burton said he suspects the new Omicron coronavirus variant may e
Moderna says new Covid-19 vaccine for Omicron may be ready in early 2022<blockquote>Moderna表示针对奥密克戎的新Covid-19疫苗可能于2022年初准备就绪</blockquote>
看
2,391
回复
评论
点赞
1
编组 21备份 2
分享
举报
trace10
trace10
·
2021-11-29
Vaccines to the rescue!
非常抱歉，此主贴已删除
看
2,378
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
trace10
trace10
·
2021-11-27
New variants going to keep popping up...[思考]
Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.<blockquote>疫苗股早盘持续走高，Moderna股价大涨超23%。</blockquote>
Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech
Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.<blockquote>疫苗股早盘持续走高，Moderna股价大涨超23%。</blockquote>
看
2,460
回复
评论
点赞
4
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4092352968542350","uuid":"4092352968542350","gmtCreate":1629422628882,"gmtModify":1632625768975,"name":"trace10","pinyin":"trace10","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":25,"headSize":98,"tweetSize":71,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":698782618,"gmtCreate":1640558376686,"gmtModify":1640558376989,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"Buy <a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>[Thinking] [Victory] ","listText":"Buy <a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>[Thinking] [Victory] ","text":"Buy $ARK Innovation ETF(ARKK)$[Thinking] [Victory]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698782618","repostId":"2193178197","repostType":4,"isVote":1,"tweetType":1,"viewCount":3625,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606438430,"gmtCreate":1638918584829,"gmtModify":1638918585050,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"Heading in the right direction [Grin] ","listText":"Heading in the right direction [Grin] ","text":"Heading in the right direction [Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606438430","repostId":"2189719656","repostType":2,"isVote":1,"tweetType":1,"viewCount":3705,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606955810,"gmtCreate":1638828069734,"gmtModify":1638828070022,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"Taking a breather","listText":"Taking a breather","text":"Taking a breather","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/606955810","repostId":"1167580246","repostType":4,"repost":{"id":"1167580246","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638802452,"share":"https://www.laohu8.com/m/news/1167580246?lang=zh_CN&edition=full","pubTime":"2021-12-06 22:54","market":"us","language":"en","title":"Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1167580246","media":"Tiger Newspress","summary":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Se","content":"<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.</p><p><blockquote>半导体股早盘下跌。英伟达、台积电、ASML、AMD、赛灵思、格芯和安森美半导体跌幅在2%至7%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 22:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.</p><p><blockquote>半导体股早盘下跌。英伟达、台积电、ASML、AMD、赛灵思、格芯和安森美半导体跌幅在2%至7%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TXN":"德州仪器","QCOM":"高通","MRVL":"迈威尔科技","GFS":"GLOBALFOUNDRIES Inc.","TSM":"台积电","AMD":"美国超微公司","MU":"美光科技","NVDA":"英伟达","ADI":"亚德诺","ON":"安森美半导体","ASML":"阿斯麦"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167580246","content_text":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.","news_type":1,"symbols_score_info":{"XLNX":0.9,"ADI":0.9,"NVDA":0.9,"TSM":0.9,"ASML":0.9,"GFS":0.9,"TXN":0.9,"QCOM":0.9,"AMD":0.9,"MU":0.9,"ON":0.9,"MRVL":0.9}},"isVote":1,"tweetType":1,"viewCount":3812,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606955332,"gmtCreate":1638828002526,"gmtModify":1638828002526,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"Great news [Grin] ","listText":"Great news [Grin] ","text":"Great news [Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606955332","repostId":"1189410190","repostType":4,"repost":{"id":"1189410190","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638804387,"share":"https://www.laohu8.com/m/news/1189410190?lang=zh_CN&edition=full","pubTime":"2021-12-06 23:26","market":"us","language":"en","title":"Stocks linked to the reopening of the economy gained on Monday<blockquote>与经济重新开放相关的股票周一上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189410190","media":"Tiger Newspress","summary":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel book","content":"<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.</p><p><blockquote>与经济重新开放相关的股票周一上涨。航空公司、邮轮公司和旅游预订股票在早盘交易中上涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks linked to the reopening of the economy gained on Monday<blockquote>与经济重新开放相关的股票周一上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks linked to the reopening of the economy gained on Monday<blockquote>与经济重新开放相关的股票周一上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 23:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.</p><p><blockquote>与经济重新开放相关的股票周一上涨。航空公司、邮轮公司和旅游预订股票在早盘交易中上涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BKNG":"Booking Holdings","BA":"波音","NCLH":"挪威邮轮","AAL":"美国航空","JBLU":"捷蓝航空","SAVE":"Spirit Airlines","ALK":"阿拉斯加航空集团有限公司","EXPE":"Expedia","ABNB":"爱彼迎","RCL":"皇家加勒比邮轮","DAL":"达美航空","LUV":"西南航空","UAL":"联合大陆航空","CCL":"嘉年华邮轮"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189410190","content_text":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.","news_type":1,"symbols_score_info":{"BA":0.9,"NCLH":0.9,"ABNB":0.9,"AAL":0.9,"BKNG":0.9,"CCL":0.9,"EXPE":0.9,"JBLU":0.9,"SAVE":0.9,"LUV":0.9,"UAL":0.9,"RCL":0.9,"DAL":0.9,"ALK":0.9}},"isVote":1,"tweetType":1,"viewCount":2914,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608035635,"gmtCreate":1638580081811,"gmtModify":1638580081930,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"Do we REALLY need another vaccine shot to counter Omicron???[Facepalm] ","listText":"Do we REALLY need another vaccine shot to counter Omicron???[Facepalm] ","text":"Do we REALLY need another vaccine shot to counter Omicron???[Facepalm]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608035635","repostId":"1154256555","repostType":4,"repost":{"id":"1154256555","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638523084,"share":"https://www.laohu8.com/m/news/1154256555?lang=zh_CN&edition=full","pubTime":"2021-12-03 17:18","market":"us","language":"en","title":"Novavax stock surged more than 7% in premarket trading<blockquote>Novavax股价在盘前交易中飙升逾7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1154256555","media":"Tiger Newspress","summary":"Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron","content":"<p>Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron-specific vaccine in January.</p><p><blockquote>Novavax股价在盘前交易中飙升超过7%，Novavax表示可能会在1月份开始生产奥密克戎专用疫苗。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/25019bf4a8dc635b8734c21361f7c7d0\" tg-width=\"852\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Novavax Inc said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.</p><p><blockquote>Novavax Inc周四表示，可能会在明年1月开始商业生产针对奥密克戎冠状病毒变种量身定制的COVID-19疫苗，同时测试其目前的疫苗是否对该变种有效。</blockquote></p><p> Laboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.</p><p><blockquote>该公司表示，预计未来几周的实验室数据将显示之前接受过Novavax COVID-19注射的个人的抗体是否可以中和该变种。</blockquote></p><p> Novavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.</p><p><blockquote>Novavax还表示，它已经开始开发一种奥密克戎特异性刺突蛋白抗原，并将在几周内开始针对该变种的新疫苗的实验室测试。</blockquote></p><p> The Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.</p><p><blockquote>奥密克戎冠状病毒变种震动了市场，并引起了全球的恐慌，人们担心它是否会逃避广泛使用的疫苗提供的保护，并延长公共卫生危机。</blockquote></p><p> Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots.</p><p><blockquote>包括Moderna和辉瑞在内的其他疫苗制造商也开始研究奥密克戎定制的COVID-19疫苗。</blockquote></p><p> Novavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.</p><p><blockquote>Novavax的COVID-19疫苗于11月初在印度尼西亚首次获得紧急使用批准，随后在菲律宾获得批准。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax stock surged more than 7% in premarket trading<blockquote>Novavax股价在盘前交易中飙升逾7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax stock surged more than 7% in premarket trading<blockquote>Novavax股价在盘前交易中飙升逾7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-03 17:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron-specific vaccine in January.</p><p><blockquote>Novavax股价在盘前交易中飙升超过7%，Novavax表示可能会在1月份开始生产奥密克戎专用疫苗。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/25019bf4a8dc635b8734c21361f7c7d0\" tg-width=\"852\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Novavax Inc said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.</p><p><blockquote>Novavax Inc周四表示，可能会在明年1月开始商业生产针对奥密克戎冠状病毒变种量身定制的COVID-19疫苗，同时测试其目前的疫苗是否对该变种有效。</blockquote></p><p> Laboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.</p><p><blockquote>该公司表示，预计未来几周的实验室数据将显示之前接受过Novavax COVID-19注射的个人的抗体是否可以中和该变种。</blockquote></p><p> Novavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.</p><p><blockquote>Novavax还表示，它已经开始开发一种奥密克戎特异性刺突蛋白抗原，并将在几周内开始针对该变种的新疫苗的实验室测试。</blockquote></p><p> The Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.</p><p><blockquote>奥密克戎冠状病毒变种震动了市场，并引起了全球的恐慌，人们担心它是否会逃避广泛使用的疫苗提供的保护，并延长公共卫生危机。</blockquote></p><p> Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots.</p><p><blockquote>包括Moderna和辉瑞在内的其他疫苗制造商也开始研究奥密克戎定制的COVID-19疫苗。</blockquote></p><p> Novavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.</p><p><blockquote>Novavax的COVID-19疫苗于11月初在印度尼西亚首次获得紧急使用批准，随后在菲律宾获得批准。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154256555","content_text":"Novavax stock surged more than 7% in premarket trading as Novavax said it could start making Omicron-specific vaccine in January.\n\nNovavax Inc said on Thursday it could begin commercial manufacturing of a COVID-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.\nLaboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's COVID-19 shot can neutralize the variant, according to the company.\nNovavax also said it has started developing an Omicron-specific spike protein antigen and will begin laboratory tests of a new vaccine to target the variant in a few weeks.\nThe Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis.\nOther vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots.\nNovavax's COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2835,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608032917,"gmtCreate":1638579987517,"gmtModify":1638579987636,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"Vaccine manufactures are the big winners in this pandemic[Allin] [USD] ","listText":"Vaccine manufactures are the big winners in this pandemic[Allin] [USD] ","text":"Vaccine manufactures are the big winners in this pandemic[Allin] [USD]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608032917","repostId":"1144924535","repostType":4,"repost":{"id":"1144924535","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638533072,"share":"https://www.laohu8.com/m/news/1144924535?lang=zh_CN&edition=full","pubTime":"2021-12-03 20:04","market":"us","language":"en","title":"Moderna stock jumped more than 5% in premarket trading<blockquote>Moderna股价在盘前交易中上涨超过5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144924535","media":"老虎资讯综合","summary":"Moderna stock jumped more than 5% in premarket trading because Moderna led with antibody response in","content":"<p>Moderna stock jumped more than 5% in premarket trading because Moderna led with antibody response in COVID-19 booster trial in U.K..</p><p><blockquote>Moderna股价在盘前交易中上涨超过5%，因为Moderna在英国的COVID-19加强试验中领先抗体反应。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7b43bf58e1f0e28dcfc0f4c263ef6736\" tg-width=\"853\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> According to a peer-reviewed study published in <i>The Lancet</i> on Thursday, Moderna COVID-19 vaccine has shown the strongest antibody effect in a trial that evaluated the different combinations of COVID-19 vaccines as boosters.</p><p><blockquote>根据发表在<i>柳叶刀</i>周四，Moderna新冠肺炎疫苗在一项评估新冠肺炎疫苗不同组合作为加强剂的试验中显示出最强的抗体效果。</blockquote></p><p> The Phase 2 \"COV-Boost\" study conducted across 18 different U.K. locations involved nearly 2,900 individuals aged over 30 years. Half in the study had received two doses of Oxford-AstraZeneca vaccine, and the rest had received the Pfizer/BioNTec vaccine.</p><p><blockquote>第二阶段“COV-Boost”研究在英国18个不同地点进行，涉及近2,900名年龄超过30岁的人。研究中有一半人接种了两剂牛津-阿斯利康疫苗，其余人接种了辉瑞/BioNTec疫苗。</blockquote></p><p> The trial was designed to evaluate the safety and efficacy of seven booster vaccines developed by AstraZeneca, Pfizer/ BioNTech, Novavax, Johnson & Johnson, Moderna, Valneva and Curevac.</p><p><blockquote>该试验旨在评估阿斯利康、辉瑞/BioNTech、Novavax、强生、Moderna、Valneva和Curevac开发的7种加强疫苗的安全性和有效性。</blockquote></p><p> While all seven vaccines except Valneva’s (VALN) boosted immunity in those who had received initial doses of Pfizer/ BioNTech, all seven had upped the immunity level when given 10 – 12 weeks after the initial regimen of the AstraZeneca vaccine.</p><p><blockquote>虽然除了Valneva(VALN)之外，所有七种疫苗都增强了接受辉瑞/BioNTech初始剂量的人的免疫力，但在阿斯利康疫苗初始方案后10-12周接种时，所有七种疫苗都提高了免疫水平。</blockquote></p><p> Notably, Moderna COVID-19 shot had generated the strongest booster effect leading to an over 32-fold rise in antibody level in the AstraZeneca group and over 11-fold increase in the Pfizer/ BioNTech group, <i>The Guardian</i> reported.</p><p><blockquote>值得注意的是，Moderna COVID-19疫苗产生了最强的加强效果，导致阿斯利康组的抗体水平上升超过32倍，辉瑞/BioNTech组的抗体水平上升超过11倍，<i>卫报</i>据报道。</blockquote></p><p> In addition,Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the new Omicron variant.</p><p><blockquote>此外，英国周三表示，已同意再购买1.14亿剂辉瑞/BioNTech和Moderna COVID-19疫苗，并表示鉴于新奥密克戎变种的出现，英国已加快签署新合同。</blockquote></p><p> The deal involves an additional 60 million Moderna shots and 54 million Pfizer doses for next year and 2023, and will also include access to any modified vaccinations if they are needed to combat the Omicron strain or any other variant, the British health ministry said.</p><p><blockquote>英国卫生部表示，该交易涉及明年和2023年额外注射6000万剂Moderna疫苗和5400万剂辉瑞疫苗，还将包括在需要对抗奥密克戎病毒株或任何其他变种时获得任何改良疫苗。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna stock jumped more than 5% in premarket trading<blockquote>Moderna股价在盘前交易中上涨超过5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna stock jumped more than 5% in premarket trading<blockquote>Moderna股价在盘前交易中上涨超过5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-12-03 20:04</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Moderna stock jumped more than 5% in premarket trading because Moderna led with antibody response in COVID-19 booster trial in U.K..</p><p><blockquote>Moderna股价在盘前交易中上涨超过5%，因为Moderna在英国的COVID-19加强试验中领先抗体反应。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7b43bf58e1f0e28dcfc0f4c263ef6736\" tg-width=\"853\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> According to a peer-reviewed study published in <i>The Lancet</i> on Thursday, Moderna COVID-19 vaccine has shown the strongest antibody effect in a trial that evaluated the different combinations of COVID-19 vaccines as boosters.</p><p><blockquote>根据发表在<i>柳叶刀</i>周四，Moderna新冠肺炎疫苗在一项评估新冠肺炎疫苗不同组合作为加强剂的试验中显示出最强的抗体效果。</blockquote></p><p> The Phase 2 \"COV-Boost\" study conducted across 18 different U.K. locations involved nearly 2,900 individuals aged over 30 years. Half in the study had received two doses of Oxford-AstraZeneca vaccine, and the rest had received the Pfizer/BioNTec vaccine.</p><p><blockquote>第二阶段“COV-Boost”研究在英国18个不同地点进行，涉及近2,900名年龄超过30岁的人。研究中有一半人接种了两剂牛津-阿斯利康疫苗，其余人接种了辉瑞/BioNTec疫苗。</blockquote></p><p> The trial was designed to evaluate the safety and efficacy of seven booster vaccines developed by AstraZeneca, Pfizer/ BioNTech, Novavax, Johnson & Johnson, Moderna, Valneva and Curevac.</p><p><blockquote>该试验旨在评估阿斯利康、辉瑞/BioNTech、Novavax、强生、Moderna、Valneva和Curevac开发的7种加强疫苗的安全性和有效性。</blockquote></p><p> While all seven vaccines except Valneva’s (VALN) boosted immunity in those who had received initial doses of Pfizer/ BioNTech, all seven had upped the immunity level when given 10 – 12 weeks after the initial regimen of the AstraZeneca vaccine.</p><p><blockquote>虽然除了Valneva(VALN)之外，所有七种疫苗都增强了接受辉瑞/BioNTech初始剂量的人的免疫力，但在阿斯利康疫苗初始方案后10-12周接种时，所有七种疫苗都提高了免疫水平。</blockquote></p><p> Notably, Moderna COVID-19 shot had generated the strongest booster effect leading to an over 32-fold rise in antibody level in the AstraZeneca group and over 11-fold increase in the Pfizer/ BioNTech group, <i>The Guardian</i> reported.</p><p><blockquote>值得注意的是，Moderna COVID-19疫苗产生了最强的加强效果，导致阿斯利康组的抗体水平上升超过32倍，辉瑞/BioNTech组的抗体水平上升超过11倍，<i>卫报</i>据报道。</blockquote></p><p> In addition,Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the new Omicron variant.</p><p><blockquote>此外，英国周三表示，已同意再购买1.14亿剂辉瑞/BioNTech和Moderna COVID-19疫苗，并表示鉴于新奥密克戎变种的出现，英国已加快签署新合同。</blockquote></p><p> The deal involves an additional 60 million Moderna shots and 54 million Pfizer doses for next year and 2023, and will also include access to any modified vaccinations if they are needed to combat the Omicron strain or any other variant, the British health ministry said.</p><p><blockquote>英国卫生部表示，该交易涉及明年和2023年额外注射6000万剂Moderna疫苗和5400万剂辉瑞疫苗，还将包括在需要对抗奥密克戎病毒株或任何其他变种时获得任何改良疫苗。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144924535","content_text":"Moderna stock jumped more than 5% in premarket trading because Moderna led with antibody response in COVID-19 booster trial in U.K..\n\nAccording to a peer-reviewed study published in The Lancet on Thursday, Moderna COVID-19 vaccine has shown the strongest antibody effect in a trial that evaluated the different combinations of COVID-19 vaccines as boosters.\nThe Phase 2 \"COV-Boost\" study conducted across 18 different U.K. locations involved nearly 2,900 individuals aged over 30 years. Half in the study had received two doses of Oxford-AstraZeneca vaccine, and the rest had received the Pfizer/BioNTec vaccine.\nThe trial was designed to evaluate the safety and efficacy of seven booster vaccines developed by AstraZeneca, Pfizer/ BioNTech, Novavax, Johnson & Johnson, Moderna, Valneva and Curevac.\nWhile all seven vaccines except Valneva’s (VALN) boosted immunity in those who had received initial doses of Pfizer/ BioNTech, all seven had upped the immunity level when given 10 – 12 weeks after the initial regimen of the AstraZeneca vaccine.\nNotably, Moderna COVID-19 shot had generated the strongest booster effect leading to an over 32-fold rise in antibody level in the AstraZeneca group and over 11-fold increase in the Pfizer/ BioNTech group, The Guardian reported.\nIn addition,Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the new Omicron variant.\nThe deal involves an additional 60 million Moderna shots and 54 million Pfizer doses for next year and 2023, and will also include access to any modified vaccinations if they are needed to combat the Omicron strain or any other variant, the British health ministry said.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2722,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609575019,"gmtCreate":1638314680860,"gmtModify":1638318799282,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"OMG....the vaccine manufacturers need several months to mass produce a vaccine that would be effective against omicron [流泪] ","listText":"OMG....the vaccine manufacturers need several months to mass produce a vaccine that would be effective against omicron [流泪] ","text":"OMG....the vaccine manufacturers need several months to mass produce a vaccine that would be effective against omicron [流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609575019","repostId":"2188758534","repostType":4,"isVote":1,"tweetType":1,"viewCount":2600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600218482,"gmtCreate":1638156207650,"gmtModify":1638156207805,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"More rounds of vaccinations [白眼] ","listText":"More rounds of vaccinations [白眼] ","text":"More rounds of vaccinations [白眼]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600218482","repostId":"2186266273","repostType":4,"repost":{"id":"2186266273","kind":"news","pubTimestamp":1638143098,"share":"https://www.laohu8.com/m/news/2186266273?lang=zh_CN&edition=full","pubTime":"2021-11-29 07:44","market":"us","language":"en","title":"Moderna says new Covid-19 vaccine for Omicron may be ready in early 2022<blockquote>Moderna表示针对奥密克戎的新Covid-19疫苗可能于2022年初准备就绪</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2186266273","media":"The Straits Times","summary":"Moderna chief medical officer Paul Burton said he suspects the new Omicron coronavirus variant may e","content":"<p><div> Moderna chief medical officer Paul Burton said he suspects the new Omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year. \"We ...</p><p><blockquote><div>Moderna首席医疗官保罗·伯顿(Paul Burton)表示，他怀疑新的奥密克戎冠状病毒变种可能会躲避目前的疫苗，如果是这样，重新配制的疫苗可能会在新年伊始上市。“我们……</div></blockquote></p><p> <a href=\"http://www.straitstimes.com/world/europe/moderna-says-new-covid-19-vaccine-for-omicron-may-be-ready-in-early-2022\">网页链接</a> </div> </p><p><blockquote><a href=\"http://www.straitstimes.com/world/europe/moderna-says-new-covid-19-vaccine-for-omicron-may-be-ready-in-early-2022\">网页连接</a></blockquote></p><p></p>","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna says new Covid-19 vaccine for Omicron may be ready in early 2022<blockquote>Moderna表示针对奥密克戎的新Covid-19疫苗可能于2022年初准备就绪</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna says new Covid-19 vaccine for Omicron may be ready in early 2022<blockquote>Moderna表示针对奥密克戎的新Covid-19疫苗可能于2022年初准备就绪</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Straits Times</strong><span class=\"h-time small\">2021-11-29 07:44</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Moderna chief medical officer Paul Burton said he suspects the new Omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year. \"We ...</p><p><blockquote><div>Moderna首席医疗官保罗·伯顿(Paul Burton)表示，他怀疑新的奥密克戎冠状病毒变种可能会躲避目前的疫苗，如果是这样，重新配制的疫苗可能会在新年伊始上市。“我们……</div></blockquote></p><p> <a href=\"http://www.straitstimes.com/world/europe/moderna-says-new-covid-19-vaccine-for-omicron-may-be-ready-in-early-2022\">网页链接</a> </div> </p><p><blockquote><a href=\"http://www.straitstimes.com/world/europe/moderna-says-new-covid-19-vaccine-for-omicron-may-be-ready-in-early-2022\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.straitstimes.com/world/europe/moderna-says-new-covid-19-vaccine-for-omicron-may-be-ready-in-early-2022\">The Straits Times</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"http://www.straitstimes.com/world/europe/moderna-says-new-covid-19-vaccine-for-omicron-may-be-ready-in-early-2022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186266273","content_text":"Moderna chief medical officer Paul Burton said he suspects the new Omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year.\n\"We should know about the ability of the current vaccine to provide protection in the next couple of weeks,\" Mr Burton said on Sunday (Nov 28) on the BBC's Andrew Marr Show.\n\"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really going to be available in large quantities,\" he said.\n\"The remarkable thing about the mRNA vaccines, the Moderna platform, is that we can move very fast,\" he added.\nThe Cambridge, Massachusetts-based biotech company mobilised \"hundreds\" of staff early last Thursday, Thanksgiving Day in the United States, after news of the Omicron variant spread.\nProtection should still exist, depending on how long ago a person was vaccinated, and for now the best advice is to take one of the current Covid-19 vaccines, Mr Burton said.\n\"If people are on the fence, and you haven't been vaccinated, get vaccinated,\" he said. \"This is a dangerous-looking virus, but I think we have many tools in our armamentarium now to fight it.\"\nThe emergence of the Omicron strain has seen countries rush to clamp down on travel from southern Africa.\nFears that it could exacerbate a winter Covid-19 surge in the northern hemisphere and undermine a global economic recovery sent a wave of risk aversion across global markets last Friday that continued on Sunday when the Middle East opened for the week.\nModerna said in a release on Friday that it was working rapidly to test the current vaccine against the Omicron variant, and studying two booster candidates.\n\"Since early 2021, Moderna has advanced a comprehensive strategy to anticipate new variants of concern,\" the company said. \"The company has repeatedly demonstrated the ability to advance new candidates to clinical testing in 60 to 90 days.\"","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2391,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600218848,"gmtCreate":1638156134498,"gmtModify":1638156134610,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"Vaccines to the rescue!","listText":"Vaccines to the rescue!","text":"Vaccines to the rescue!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600218848","repostId":"1132528186","repostType":4,"isVote":1,"tweetType":1,"viewCount":2378,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877488271,"gmtCreate":1637972580986,"gmtModify":1637972586448,"author":{"id":"4092352968542350","authorId":"4092352968542350","name":"trace10","avatar":"https://static.tigerbbs.com/54e8beb357f92a42884600a8355e3fdf","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092352968542350","idStr":"4092352968542350"},"themes":[],"htmlText":"New variants going to keep popping up...[思考] ","listText":"New variants going to keep popping up...[思考] ","text":"New variants going to keep popping up...[思考]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877488271","repostId":"1125886564","repostType":4,"repost":{"id":"1125886564","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637938179,"share":"https://www.laohu8.com/m/news/1125886564?lang=zh_CN&edition=full","pubTime":"2021-11-26 22:49","market":"us","language":"en","title":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.<blockquote>疫苗股早盘持续走高，Moderna股价大涨超23%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1125886564","media":"Tiger Newspress","summary":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech ","content":"<p>Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech jumped nearly 19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p><p><blockquote>疫苗股早盘持续走高，Moderna股价大涨超23%，BioNTech大涨近19%。德国BioNTech表示，正在研究其新冠肺炎疫苗对在南非发现的新B.1.1.529变种的有效性。</blockquote></p><p> \"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p><p><blockquote>“我们预计最迟在两周内从实验室测试中获得更多数据。这些数据将提供更多信息，说明B.1.1.529是否可能是一种逃逸变体，如果该变体在全球传播，可能需要调整我们的疫苗，”BioNTech发言人表示。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.<blockquote>疫苗股早盘持续走高，Moderna股价大涨超23%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks continued to rise in early trading, Moderna shares surged more than 23%.<blockquote>疫苗股早盘持续走高，Moderna股价大涨超23%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-26 22:49</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech jumped nearly 19%.<img src=\"https://static.tigerbbs.com/2e9f40662925ec57d0176cf5f1e36df4\" tg-width=\"876\" tg-height=\"613\" referrerpolicy=\"no-referrer\">Germany's BioNTech said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.</p><p><blockquote>疫苗股早盘持续走高，Moderna股价大涨超23%，BioNTech大涨近19%。德国BioNTech表示，正在研究其新冠肺炎疫苗对在南非发现的新B.1.1.529变种的有效性。</blockquote></p><p> \"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.</p><p><blockquote>“我们预计最迟在两周内从实验室测试中获得更多数据。这些数据将提供更多信息，说明B.1.1.529是否可能是一种逃逸变体，如果该变体在全球传播，可能需要调整我们的疫苗，”BioNTech发言人表示。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125886564","content_text":"Vaccine stocks continued to rise in early trading, Moderna shares surged more than 23% and BioNTech jumped nearly 19%.Germany's BioNTech said it is studying the effectiveness of its COVID-19 vaccine against the new B.1.1.529 variant detected in South Africa - The Economic Times.\n\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" a BioNTech spokesperson said.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2460,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}